Minutes of the Research for Patient Benefit (RfPB) programme South East and Central Regional Advisory Committee meeting to discuss applications to Competition 38 Stage 2 and Competition 39 Stage 1.
Date and location
Meeting held on Wednesday 25 September 2019 at ETC Venues Ltd, Avonmouth House, 6 Avonmouth Street, London SE1 6NX
In attendance
Funding committee
Professor Carrie Llewellyn (Chair)
Mrs Wendy Blunden
Professor Stephen Bremner
Professor Simon Coulton
Professor Daniel Freeman
Ms Rosemary Greenwood
Dr Mark Hayward
Dr Christina Jones
Dr Louise Linsell
Miss Alison Provins
Profesor Najib M Rahman
Professor Simon Skene
Dr James Sheppard
Professor Ian Swaine
Mr David Turner
Dr Dawn-Marie Walker
Dr Peter Worsley
Mr Keith Wyncoll
Secretariat
Dr Laura Tornatore (NIHR CCF)
Dr Ianina Conte (NIHR CCF)
Miss Lilian Tomlinson (NIHR CCF)
Observers
Dr Emma Wilkinson (Observer – NIHR RDS East of England)
Apologies
Apologies were received from Professor Michael Calnan, Professor Julia Hippisley-Cox and Mrs Ann-Marie Towers.
Competition 38 Stage 2 applications considered
NIHR200731: HIP HELPER - Improving patient recovery following hip fracture through caregiver support: a feasibility study
Conflicts: Professor Daniel Freeman, Dr Louise Linsell and Professor Najib Rahman left the room.
Outcome: Conditional support
NIHR200747: A randomised feasibility study to assess a smartphone medication monitoring and reminder application (Medopad) in renal transplant recipients with high tacrolimus variability
Conflicts: Dr Louise Linsell remained out of the room, Miss Alison Provins left the room.
Outcome: Reject
NIHR200710: Cognitive Analytic Therapy for Containing Self-Harm in Young People (CATCH-Y): A feasibility trial
Conflicts: Professor Daniel Freeman left the room.
Outcome: Reject
NIHR201177: TMR in the prevention of neuroma related pain after below knee amputation - a feasibility study
Conflicts: Ms Rosemary Greenwood left the room.
Outcome: Reject
NIHR200753: Establishing evidence –based management of Complex Regional Pain Syndrome to improve clinical outcomes throughout the care pathway (ENACT-CRPS)
Conflicts: Ms Rosemary Greenwood remained out of the room.
Outcome: Conditional support
NIHR200755: Unscheduled ConversAtions with parents in Paediatric intensive care: The UNCAP study
Conflicts: Dr Dawn-Marie Walker and Dr Peter Worsley left the room.
Outcome: Reject
Competition 39 Stage 1 applications considered
NIHR201090: External validation and implementation of a risk prediction tool for medication-related harm in older people following hospital discharge
Conflicts: Professor Carrie Llewellyn, Professor Stephen Bremner and Dr James Sheppard left the room. Professor Daniel Freeman assumed the chair.
Outcome: Reject
NIHR201095: Prevention of Recurrent Symptomatic Urinary Tract Infections in People with Neurologically Disturbed Bladder Function: PReSUTINeB II
Conflicts: None
Outcome: Reject
NIHR201031: Anti-TNF (Adalimumab) injection for the treatment of adults with frozen shoulder during the pain-predominant phase: a multi-centre, randomised, double blind, parallel group, feasibility study
Conflicts: Professor Daniel Freeman, Dr Louise Linsell and Professor Najib Rahman left the room.
Outcome: Invite to Stage 2
NIHR201093: Evaluation of the feasibility of a RCT of Empowered Conversations: a training to enhance relationships and communication between family carers and people living with dementia
Conflicts: None
Outcome: Invite to Stage 2
NIHR201036: REST: A prospective randomised feasibility study assessing the impact of a tailored sleep intervention in patients undergoing total knee replacement
Conflicts: Professor Carrie Llewellyn and Ms Rosemary Greenwood left the room. Professor Daniel Freeman assumed the chair.Outcome: Invite to Stage 2
NIHR201032: A qualitative investigation of the attitudes towards infant feeding of new mothers living with HIV in the UK
Conflicts: Professor Carrie Llewellyn remained out of the room. Dr James Sheppard left the room.
Outcome: Invite to Stage 2
NIHR201153: A feasibility study for two simultaneous randomised controlled trials to compare the effectiveness of two techniques for managing pain in upper and lower tooth extractions
Conflicts: Professor Carrie Llewellyn remained out of the room. Ms Rosemary Greenwood left the room.
Outcome: Invite to Stage 2
NIHR201020: Brinzolamide eye-drops to treat nystagmus: A feasibility study and Core Outcome Set (COS) evaluation prior to a planned RCT
Conflicts: Dr Dawn-Marie Walker and Dr Peter Worsley left the room.
Outcome: Invite to Stage 2
NIHR201042: Functional Imagery Training to reduce alcohol-related harm in patients with alcoholic hepatitis: a randomised feasibility study
Conflicts: Professor Carrie Llewellyn and Ms Rosemary Greenwood left the room. Professor Daniel Freeman assumed the chair.
Outcome: Reject
NIHR201130: Building resilience in breast cancer patients using adaptive cognitive training: A randomised control trial
Conflicts: Professor Najib Rahman left the room.
Outcome: Reject
NIHR201141: Statin Treatment Options during vaccination against inFLUenza (STOPFlu) : a study of the interaction between statins and influenza vaccination
Conflicts: None
Outcome: Invite to Stage 2
NIHR201114: Developing an intervention to improve the communication of children with developmental language disorder through collaborative groupwork: a mixed methods study with children aged 7-11 years
Conflicts: None
Outcome: Reject
NIHR201033: A service evaluation of innovations designed to facilitate the timely discharge from hospital of older patients living with frailty
Conflicts: Professor Najib Rahman and Dr James Sheppard left the room.
Outcome: Reject
Outcomes tables
This table displays the mean score for each application that was assessed in the regional assessment committee meeting, and excludes applications that were rejected during the scrutiny and triage processes. Applications are listed according to mean score and outcome. The RfPB fundable range is 6-10 although a score of 6-10 does not guarantee funding. In exceptional circumstances and with approval from the Programme Director, applications may be invited/funded which fall below the fundable range.
Competition 38 Stage 2
| Score | Range | Number of applications |
|---|---|---|
| 10 | Fundable | 0 |
| 9 | Fundable | 0 |
| 8 | Fundable | 0 |
| 7 | Fundable | 2 |
| 6 | Fundable | 0 |
| 5 | Rejected | 4 |
| 4 | Rejected | 0 |
| 3 | Rejected | 0 |
| 2 | Rejected | 0 |
| 1 | Rejected | 0 |
Competition 39 Stage 1
| Score | Range | Number of applications |
|---|---|---|
| 10 | Fundable | 0 |
| 9 | Fundable | 0 |
| 8 | Fundable | 0 |
| 7 | Fundable | 1 |
| 6 | Fundable | 6 |
| 5 | Rejected | 1 |
| 4 | Rejected | 3 |
| 3 | Rejected | 2 |
| 2 | Rejected | 0 |
| 1 | Rejected | 0 |